Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Non-Current Assets (2023 - 2025)

Beta Bionics (BBNX) has disclosed Non-Current Assets for 3 consecutive years, with $60.8 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 263.82% to $60.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $240.9 million through Dec 2025, changed N/A year-over-year, with the annual reading at $60.8 million for FY2025, 263.82% up from the prior year.
  • Non-Current Assets hit $60.8 million in Q4 2025 for Beta Bionics, up from $60.0 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $76.1 million in Q1 2025 to a low of $6.4 million in Q4 2023.
  • Historically, Non-Current Assets has averaged $44.0 million across 3 years, with a median of $52.0 million in 2025.
  • Biggest five-year swings in Non-Current Assets: surged 160.51% in 2024 and later soared 263.82% in 2025.
  • Year by year, Non-Current Assets stood at $6.4 million in 2023, then soared by 160.51% to $16.7 million in 2024, then skyrocketed by 263.82% to $60.8 million in 2025.
  • Business Quant data shows Non-Current Assets for BBNX at $60.8 million in Q4 2025, $60.0 million in Q3 2025, and $43.9 million in Q2 2025.